Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

244
Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
244
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

341
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
341
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

347
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
347
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

322
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
322
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

155
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
155
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

243
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
243

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Computational approaches to DMPK: A realistic assessment of current methods and their practical impact. Part I: Physicochemical and in vitro properties.

Drug discovery today·2025
Same author

Machine Learning Prediction and Validation of Plasma Concentration-Time Profiles.

Molecular pharmaceutics·2025
Same author

A Practical <i>In Silico</i> Method for Predicting Compound Brain Concentration-Time Profiles: Combination of PK Modeling and Machine Learning.

Molecular pharmaceutics·2024
Same author

Prediction of Inhibitory Activity against the MATE1 Transporter via Combined Fingerprint- and Physics-Based Machine Learning Models.

Journal of chemical information and modeling·2024
Same author

Development of a Novel In Silico Classification Model to Assess Reactive Metabolite Formation in the Cysteine Trapping Assay and Investigation of Important Substructures.

Biomolecules·2024
Same author

Development of Novel Methods for QSAR Modeling by Machine Learning Repeatedly: A Case Study on Drug Distribution to Each Tissue.

Journal of chemical information and modeling·2024

相关实验视频

Updated: Jan 18, 2026

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

2.0K

基于分数的线性推断 (FLEX) 方法用于预测人类的药理动力学清除:先进的全米缩放方法和机器学习方法.

Yuki Umemori1, Koichi Handa2, Saki Yoshimura1

  • 1Axcelead Tokyo West Partners, Inc. Translational Science, Discovery DMPK, Hino-Shi, Tokyo, 191-0065, Japan.

Pharmaceutical research
|September 10, 2025
PubMed
概括

准确的人类清除预测对于药物开发至关重要. 结合基于值的缩放和机器学习的新方法改善了低未结合分数的化合物的预测,有助于早期药物决策.

关键词:
全度尺度缩放法 (Allometric Scaling) 是一种全度尺度缩放法.清除许可证是什么意思药物发现 药物发现机器学习是机器学习.它与等离子体蛋白质结合.

更多相关视频

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.6K

相关实验视频

Last Updated: Jan 18, 2026

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

2.0K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.6K

科学领域:

  • 药理动力学和药物新陈代谢
  • 计算化学和化学信息学
  • 药物发现和开发 药物发现和开发

背景情况:

  • 准确预测人类清除 (CL) 在早期药物开发中至关重要.
  • 使用大鼠药理动力学 (PK) 数据的单个物种缩放 (SSS) 是常见的,但对于具有非常低不结合的血分数 (fu,plasma) 的化合物来说不那么准确.
  • 现有的方法缺乏系统的方法来解决SSS对具有极低fu,等离子体的化合物的局限性.

研究的目的:

  • 开发和验证一种新的方法来改善人类的CL预测,特别是对于低fu,等离子体的化合物.
  • 通过使用独立数据集,系统验证单个物种规模化无约束 (SSS fu Rat) 方法.
  • 整合基于值的测量法与机器学习,以提高预测准确度.

主要方法:

  • 开发了基于分数的线性外推SSS (FLEX-SSS fu Rat),一种基于优化的fu值在SSS fu Rat和SSS Rat之间自适应地切换的方法.
  • 通过使用200个化合物的训练集,推导出最佳值和缩放系数.
  • 使用分子描述符构建了一个随机森林 (RF) 机器学习模型,并使用62个化合物的外部数据集验证了这两种模型.

主要成果:

  • 所有五种预测模型都显示了可比性能.
  • 一个结合FLEX-SSS fu鼠和RF的共识模型取得了最好的结果.
  • 协商一致的模型预测了人类的CL在40.3%的化合物的2倍误差内,只有16.1%的化合物超过5倍误差,几何平均折叠误差 (GMFE) 为2.7.

结论:

  • 这项研究提供了SSS fu Rat在独立数据集上的首次系统验证.
  • 基于值的全度测量和机器学习的整合显著提高了人类CL预测的准确性.
  • 开发的方法支持在药物开发中为人类首次剂量选择做出更明智的决策.